| Literature DB >> 35163849 |
Chunling Wang1, Miaomiao Hou1,2, Kunyu Shang3, Huanshan Wang1, Jianwei Wang1.
Abstract
Microplastics are environmental contaminants and an emergent concern. Microplastics are abundant in freshwater and can cause biochemical stress in freshwater organisms. In the current study, rare minnows (Gobiocypris rarus) were exposed to 1μm polystyrene microplastics at 200 μg/L concentration. We observed various sublethal effects after four weeks of exposure but no mortality. Numerous cellular and tissue alterations were observed in the liver. Differential metabolites and differentially expressed genes between control and exposure groups were identified and mapped to pathways in the Kyoto Encyclopedia of Genes and Genomes. The combination of transcriptomic and metabolomic analyses revealed significantly varied metabolic pathways between the two groups. These pathways were involved in glucolipid, amino acid, and nucleotide metabolism. Results demonstrated that MP exposure induced immune reaction, oxidative stress, and disturbed glycolipid and energy metabolism. The current study provided novel insights into the molecular and metabolic mechanisms of microplastic ecotoxicology in rare minnow.Entities:
Keywords: energy metabolism; fishes; lipid metabolism; oxidative stress; plastic pollution
Mesh:
Substances:
Year: 2022 PMID: 35163849 PMCID: PMC8840292 DOI: 10.3390/molecules27030584
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Physical and chemical characteristics of the test water.
| Group | Before/After | Dissolved | Conductivity (μs/cm) | pH | Temperature (°C) |
|---|---|---|---|---|---|
| Control | before | 7.55 ± 0.36 | 747 ± 7 | 8.03 ± 0.17 | 26.8 ± 1.1 |
| after | 7.77 ± 0.15 | 732 ± 3 | 8.29 ± 0.06 | 27.3 ± 0.9 | |
| MPs-treated | before | 7.57 ± 0.46 | 750 ± 9 | 8.04 ± 0.22 | 26.6 ± 1.2 |
| after | 7.71 ± 0.20 | 734 ± 2 | 8.25 ± 0.07 | 27.1 ± 1.0 |
Figure 1Liver tissues of rare minnow. (A,C) Normal appearance of the control liver. (B) The liver was exposed to 200 μg/L MPs solution showing cell hypertrophy and increased vacuolization in hepatocytes compared with the control. (D) The liver exposed to 200 μg/L MPs shows a larger area and daker color of the lipid droplets than the control.
Figure 2Volcano plot of DEGs. Upregulated genes are shown as red dots, whereas downregulated genes are shown as blue dots.
Figure 3Transcriptome analysis of rare minnows exposed to 200 μg/L MPs compared with the control group. (A) GO enrichment analysis. (B) KEGG pathway analysis.
The top 20 DEGs after MP exposure.
| Gene Name | Description | Log2fc | Q-Value | Biological Process | Function |
|---|---|---|---|---|---|
| hutU | urocanate hydratase | −12.08 | 5.27 × 10−254 | Histidine metabolism | Catalyzes the conversion of urocanic acid |
| C3 | Complement | −11.71 | 2.10 × 10−210 | Immune process | Part of the complement system |
| UGT | glucuronosyltransferase | −11.43 | 1.25 × 10−181 | Glucuronidation | Making relative enzymes |
| C1R | Complement | −11.24 | 1.66 × 10−164 | Immune process | Part of the complement system |
| MHC1 | major histocompatibility complex | −10.96 | 3.80 × 10−142 | Immune process | Making proteins in certain immune system cells |
| FKBP4 | FK506-binding protein 4 | −9.89 | 2.23 × 10−80 | Immune process | Signal transduction |
| HSD11B2 | corticosteroid 11-beta-dehydrogenase | −9.57 | 8.38 × 10−68 | Immune process | Modulates intracellular glucocorticoid levels |
| FMN2 | formin 2 | −8.90 | 5.06 × 10−47 | Organismal Systems | Development |
| RAP1GAP | RAP1 GTPase activating protein 1 | 9.60 | 8.43 × 10−68 | Cancer tumorigenesis | GTPase activator |
| NRAS | GTPase NRas | 9.67 | 1.35 × 10−70 | Cell division | Signal transduction |
| RELA | transcription factor p65 | 9.69 | 2.28 × 10−71 | Inflammatory reaction | Signal transduction |
| C4 | Complement | 10.52 | 6.84 × 10−111 | Immune process | Part of the complement system |
| TACC3 | transforming acidic coiled-coil-containing protein 3 | 10.59 | 2.30 × 10−115 | Cell growth and | Signal transduction |
| CAMK1 | calcium/calmodulin- | 10.61 | 1.48 × 10−116 | Cell growth and death | Signal transduction |
| TF | transferrin | 10.65 | 2.84 × 10−119 | Environmental Information Process | Signal transduction |
| A2M | alpha-2-macroglobulin | 10.79 | 3.15 × 10−128 | Immune process | Proteinase inhibitor |
| PLAUR | plasminogen activator, urokinase receptor | 9.35 | 3.49 × 10−59 | Immune process | Signal transduction |
| RNF19A | E3 ubiquitin-protein | 9.25 | 3.81 × 10−56 | Genetic Information Process | Translation |
| SHOC2 | leucine-rich repeat | 9.04 | 6.74 × 10−50 | Environmental | Signal transduction |
| ALDH | aldehyde | 8.74 | 2.74 × 10−42 | Metabolism process | Producing aldehyde |
List of statistically significant tentatively identified metabolites to differentiate between control and MPs-exposed rare minnow liver samples.
| Compound | Molecular Formula | Mode | Measured | Mass Error (ppm) | Fold-Change | Trend | Kegg C-Code | |
|---|---|---|---|---|---|---|---|---|
| 2-Formylglutarate | C6H8O5 | ESI- | 159.0293 | −3.91076 | 0.64 | down | 0.002 | C16159 |
| 2-Dehydro-3-deoxy- | C6H10O6 | ESI- | 177.04 | −2.53718 | 0.63 | down | 0.001 | C01216 |
| C6H10O6 | ESI- | 177.04 | −2.53718 | 0.63 | down | 0.001 | C02669 | |
| C6H10O6 | ESI- | 177.04 | −2.53718 | 0.63 | down | 0.001 | C21955 | |
| C6H15O9P | ESI- | 307.043 | −2.00474 | 0.67 | down | 0.023 | C00644 | |
| C6H12O7 | ESI- | 195.0505 | −2.85294 | 0.61 | down | 0.001 | C00817 | |
| C5H10O5 | ESI- | 195.0505 | −3.72763 | 0.61 | down | 0.001 | C01508 | |
| C5H10O5 | ESI- | 195.0505 | −3.72763 | 0.61 | down | 0.001 | C00121 | |
| C5H10O5 | ESI- | 195.0505 | −3.72763 | 0.61 | down | 0.001 | C00476 | |
| C6H12O7 | ESI- | 195.0505 | −2.85294 | 0.61 | down | 0.001 | C00514 | |
| (S)-3-Hydroxyisobutyryl-CoA | C25H42N7O18P3S | ESI- | 852.1423 | −2.79862 | 0.59 | down | 0.044 | C06000 |
| Sphingosyl-phosphocholine | C23H50N2O5P+ | ESI- | 510.3457 | 3.888599 | 0.64 | down | 0.040 | C03640 |
| N-Acetyl- | C11H13NO3 | ESI- | 252.087 | −3.40067 | 0.68 | down | 0.048 | C05620 |
| N-Acetyl- | C11H13NO3 | ESI- | 252.087 | −3.40067 | 0.68 | down | 0.048 | C03519 |
| C6H12O7 | ESI+ | 219.0459 | −8.34259 | 0.67 | down | 0.010 | C00514 | |
| C6H12O7 | ESI+ | 219.0459 | −8.34259 | 0.67 | down | 0.010 | C00817 | |
| 5-Hydroxyindoleacetate | C10H9NO3 | ESI+ | 192.0659 | 1.905397 | 0.61 | down | 0.044 | C05635 |
| (R)-3,3-Dimethylmalate | C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C01088 |
| C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C18028 | |
| (S)-2-(Hydroxymethyl)glutarate | C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C16390 |
| 2-Dehydro-3-deoxy- | C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C03827 |
| 3-Ethylmalate | C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C01989 |
| (2R,3S)-2,3-Dimethylmalate | C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C03652 |
| (R)-2-Ethylmalate | C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C02488 |
| 2-Dehydro-3-deoxy- | C6H10O5 | ESI+ | 180.0877 | 6.414412 | 0.66 | down | 0.016 | C03979 |
| 4-Methyl- | C6H11NO4 | ESI+ | 144.0655 | -0.08917 | 0.48 | down | 0.006 | C06234 |
| alpha-1,5- | C10H18O9 | ESI- | 281.0882 | 1.31699 | 0.78 | down | 0.004 | C20570 |
| beta- | C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C00663 |
| beta- | C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C05345 |
| alpha- | C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C00668 |
| C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C00275 | |
| C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C01097 | |
| C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C01094 | |
| C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C18096 | |
| C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C15924 | |
| beta- | C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C01172 |
| C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C02962 | |
| N-Acetylneuraminate 9-phosphate | C11H20NO12P | ESI+ | 428.037 | 3.966776 | 1.57 | up | 0.000 | C06241 |
| Cytosine | C4H5N3O | ESI+ | 112.0506 | 0.697346 | 1.76 | up | 0.002 | C00380 |
| C3H6O3 | ESI- | 135.0307 | 9.084401 | 1.59 | up | 0.046 | C00577 | |
| C6H13O9P | ESI+ | 283.019 | 0.420669 | 1.28 | up | 0.046 | C00085 |
Figure 4Metabolomic analysis of rare minnows exposed to 200 μg/L MPs compared with the control group.
Figure 5Comparisons of the expression profiles of 5 DEGs obtained using RNA-seq and qRT-PCR analysis. The expression levels of selected genes were normalized to β-actin rRNA.
Figure 6Integrated network of functional interactions between metabolites (represented by their KEGG C-codes) and genes (represented by their abbreviation names) whose levels were affected in rare minnow by MP exposure. Metabolites and genes are connected if they share at least one common KEGG pathway. Increased or decreased metabolite or mRNA abundances (genes) in MP-exposed samples are indicated by red and blue symbols, respectively. Standard names of some relevant metabolites are shown in green.
Figure 7Relative changes of genes and metabolite involved in glutathione metabolism.